Table 1 Description of similar patterns of more than five amino-acids obtained in vaccine antigenic proteins and SARS-CoV-2 proteins
Vaccine | No of similar segment | Vaccine protein | SARS-CoV-2 protein | ||||
|---|---|---|---|---|---|---|---|
Designation | Segment | Position | Designation | Segment | Position | ||
Poliovirus | 2 | VP1 protein (Sabin 1) | GTAPARIS | 188–195 | N | GTSPARMA | 203–211 |
VP1 protein (Sabin 3) | LDPLSE | 289–295 | S | LDPLSE | 293–299 | ||
Measles | 2 | Fusion protein | QECLRG | 359–364 | ORF6 | QECVRG | 21–27 |
IQVGSRR | 433–440 | ORF8 | IRVGARK | 47–54 | |||
Streptococcus pneumoniae | 2 | Capsular polysaccharide biosynthesis protein (serotype19F, 18C, 14, 7, 4, 1) | IGFLAGVI | 182–190 | S | LGFIAGLI | 1218–1226 |
Capsular polysaccharide biosynthesis protein (serotype19F, 18C, 14, 5) | SSVAFA | 33–39 | S | NSVAYS | 703–708 | ||
Hib | 2 | Capsular polysaccharide biosynthesis protein | KNINDS | 210–215 | S | KNLNES | 1191–1196 |
FILNKKI | 73–79 | ORF1a | FLLNKEM | 3183–3189 | |||
BCG | 1 | Immunogenic protein MPB64 | IFMLVT | 5–11 | E | VFLLVT | 25–31 |
Tetanus | 1 | Toxin protein | NILMQY | 84–90 | S | NLLLQY | 751–756 |
Mumps virus | 1 | Fusion protein | DISTEL | 448–454 | S | DISTEI | 467–473 |
Hepatitis B | 1 | HBs Ag-adr | PGTSTTS | 111–117 | S | PGTNTSN | 600–606 |